
Cortizone-10
Allegations: Falsely marketing products with 1% hydrocortisone as “maximum strength”
Sherwood et al. v. Chattem, Inc.
23-cv-3980, S.D.N.Y.
(May 2023)
Cortizone-10 hydrocortisone topical creams, ointments, gels, lotions, and liquids
Misleadingly marketing 1% hydrocortisone products as “Maximum Strength” when there are products with stronger dosages available
Pending
Allegations: Falsely marketing products with 1% hydrocortisone as “maximum strength”
Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin
Allegations: False natural claims
Allegations: False natural claims
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Makers of nasal allergy spray told to cease consumer preference claims.